Analysis of the expression of N-cadherin and survivin in an established D-17 cell line and in canine cells of a spontaneous osteosarcoma

• Autorzy: Ciaputa R. , Poradowski D. , Janus I. , Nowak M. , Obminska-Mrukowicz B. , Madej J. A. , Kandefer-Gola M.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to demonstrate and evaluate the expression of N-cadherin and survivin in spontaneous osteosarcoma tumours in dogs compared to the expression of these proteins in an established (D-17) cell line of canine osteosarcoma. Osteosarcoma samples were taken from the limbs of 15 dogs and fixed in 7% buffered formalin. An adherent canine osteosarcoma cell line (D-17) was also used for the study. The cytoplasmic expression of N-cadherin and survivin was shown in spontaneous osteosarcoma, whereas the cytoplasmic and nuclear expression of N-cadherin and survivin was observed in cells derived from the D-17 cell line. The results indicate that the higher the cytoplasmic expression of N-cadherin, the higher the expression of survivin. By analyzing the strength of intercellular adhesion, which is based on the type and strength of N-cadherin expression, as well as the degree of apoptosis inhibition, one may conclude that these markers may be used as supplementary to routine tests to evaluate the degree of the tumour’s malignancy and the patient’s prognosis.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 06
• Opis fizyczny: p.349-353,fig.,ref.

Twórcy

autor

Ciaputa R.

• Department of Pathology, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Poradowski D.

• Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Janus I.

• Department of Pathology, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Nowak M.

• Department of Pathology, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Obminska-Mrukowicz B.

• Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Madej J. A.

• Department of Pathology, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Kandefer-Gola M.

• Department of Pathology, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

Bibliografia

• 1. Brouckaert O., Paridaens R., Floris G., Rakha E., Osborne K., Neven P.: Acritical review why assessment of steroid hormone receptors in breast cancershould be quantitative. Ann. Oncol. 2013, 24, 47-53.
• 2. Burk R., Feeney A.: Small Animal Radiology and Ultrasonography: a Diagnostic Atlas and Text. Saunders, St. Louis 2003, p. 506.
• 3. Ferrari S. L., Traianedes K., Thorne M., Lafage-Proust M. H., Genever P., Cecchini M. G., Behar V., Bisello A., Chorev M., Rosenblatt M., Suva L. J.:A role for N-cadherin in the development of the differentiated osteoblasticphenotype. J. Bone. Miner. Res. 2000, 15, 198-208.
• 4. Gârjoabă I., Tudor N., Soare T., Tănase A., Alistar A., Vlăgioiu C.: A study on the prevalence of skeletal osteosarcoma in dogs and cats, Lucrări. Stiinłifice. Medicină. Veterinară. 2009, 42, 102-106.
• 5. Holmberg B. J., Farese J. P., Taylor D., Uhl E. W.: Osteosarcoma of the humeral head associated with osteochondritis dissecans in a dog. J. Am. Anim.Hosp. Assoc. 2004, 40, 246-249.
• 6. Iurlaro M., Demontis F., Corada M., Zanetta L., Drake C., Gariboldi M., eiro S., Cano A., Navarro P., Cattelino A., Tognin S., Marchisio P. C.,Dejana E.: VE-cadherin expression and clustering maintain low levels ofsurvivin in endothelial cells. Am. J. Pathol. 2004, 165, 181-189.
• 7. Kashima T., Nakamura K., Kawaguchi J., Takanashi M., Ishida T., Aburatani H., Kudo A., Fukayama M., Grigoriadis A. E.: Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int. J. Cancer 2003, 104, 147-154.
• 8. Kashima T., Kawaguchi J., Takeshita S., Kuroda M., Takanashi M., Horiuchi H., Imamura T., Ishikawa Y., Ishida T., Mori S., Machinami R., Kudo A.:Anomalous cadherin expression in osteosarcoma. Possible relationships tometastasis and morphogenesis. Am. J. Pathol. 1999, 155, 1549-1555.
• 9. Liang X., Da M., Zhuang Z., Wu W., Wu Z., Wu Y., Shen H.: Effects of survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell. Biol. Int. 2009, 33, 119-124.
• 10. Marie P. J.: Role of N-cadherin in bone formation. J. Cell. Physiol. 2002, 190, 297-305.
• 11. Mullins M. N., Lana S. E., Dernell W. S., Ogilvie G. K., Withrow S. J., Ehrhart E. J.: Cyclooxygenase-2 expression in canine appendicular osteosarcomas.J. Vet. Intern. Med. 2004, 18, 859-865.
• 12. Osaka E., Suzuki T., Osaka S., Yoshida Y., Sugita H., Asami S., Tabata K., Sugitani M., Nemoto N., Ryu J.: Survivin expression levels as independent predictors of survival for osteosarcoma patients. J. Orthop. Res. 2007, 25, 116-121.
• 13. Remmele W., Stegner H. E.: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987, 8, 138-140.
• 14. Rosenberger J. A., Pablo N. V., Crawford P. C.: Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005). J. Am. Vet. Med. Assoc. 2007, 231, 1076-1080.
• 15. Selvarajaha G. T., Kirpensteijn J.: Prognostic and predictive biomarkers of canine osteosarcoma. Veterinary Journal 2010, 185, 28-35.
• 16. Spodnick G. J., Berg J., Rand W. M., Schelling S. H., Couto G., Harvey H. J., Henderson R. A., MacEwen G., Mauldin N., McCaw D. L., et al.: Prognosisfor dogs with appendicular osteosarcoma treated by amputation alone: 162cases (1978-1988). J. Am. Vet. Med. Assoc. 1992, 200, 995-999.
• 17. Takeichi M.: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991, 25, 1451-1455.
• 18. Takeichi M.: Cadherin in cancer: implications for invasion and metastasis. Curr. Opin. Cell. Biol. 1993, 5, 806-811.
• 19. Trieb K., Lehner R., Stulnig T., Sulzbacher I., Shroyer K. R.: Survivin expression in human osteosarcoma is a marker for survival. Eur. J. Surg. Oncol.2003, 29, 379-382.
• 20. Withrow S. J., Vail M. D.: Withrow and MacEwen’s Small Animal Clinical Oncology, Saunders, St. Louis 2007, pp. 540-544.